Oral contraception. Physiologic and pathologic effects.
D000236:Adenoma / Q000139:chemically induced; D001943:Breast Neoplasms / Q000139:chemically induced; D050260:Carbohydrate Metabolism; D002277:Carcinoma / Q000139:chemically induced; D002278:Carcinoma in Situ / Q000139:chemically induced; D002561:Cerebrovascular Disorders / Q000139:chemically induced; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003327:Coronary Disease / Q000139:chemically induced; D004644:Emotions / Q000187:drug effects; D005260:Female; D005298:Fertility / Q000187:drug effects; D006261:Headache / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008113:Liver Neoplasms / Q000139:chemically induced; D010051:Ovarian Neoplasms / Q000139:chemically induced; D013923:Thromboembolism / Q000139:chemically induced; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000139:chemically induced
D003276:Contraceptives, Oral